Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with ...

Infosys, Pine Labs, ONGC, Bank of Maharashtra, Tata Capital, Lemon Tree Hotels, Vintage Coffee are among the top stocks to ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

Cold weather intensifies joint pain for Osteoarthritis sufferers due to reduced blood flow. While OA is irreversible, ...

An Osaka Metropolitan University-led research team found that patients with knee osteoarthritis show a weaker human-body ...

Osteoarthritis (OA), the most prevalent musculoskeletal disease in India, affects over 62 million people, with a prevalence ...

Decision-making for the optimal management of traumatic knee injuries can be challenging. Clinical trials reveal only small ...

Thousands of claimants of personal independent payment (PIP) will get extra cash in their bank accounts under autumn budget ...

From exercising outdoors to eating oily fish, there are a number of simple measures that can be taken to manage ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.